Evidence of Segregation of a Quinolone Antibiotic in Dipalmitoylphosphatidylcholine Environment

References

• Bergan T. Quinolones. The antimicrobial agents annual 11, P. K. Peterson, J. Verhoef. Elsevier, Amsterdam 1986; 164
   Google Scholar
• Wolfson J. S., Hooper D. C. Quinolone antimicrobial agents. Clin. Microbiol. Rev. 1989; 2: 378–424
   PubMed Web of Science ®Google Scholar
• Hoshino K., Kitamura A., Morrissey I., Sato K., Kato J.-I., Ikeda H. Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition. Antimicrob. Agents Chemother. 1994; 38: 2623–2627
   PubMed Web of Science ®Google Scholar
• Shen L. L., Mitscher L. A., Sharma P. N., O'Donnell T. J., Chu D. W. T., Cooper C. S., Rosen T., Pernet A. G. Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug-DNA binding model. Biochemistry 1989; 28: 3886–3894
   PubMed Web of Science ®Google Scholar
• Takácks-Novák K., Noszál B., Hermecz I., Keresztúri G., Podányi B., Szász G. Protonation Equilibria of quinolone antibacterials. J. Pharm. Sci. 1990; 79: 1023–1028
   PubMedGoogle Scholar
• Nikaido H. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 1994; 264: 382–388
   PubMed Web of Science ®Google Scholar
• Trias J. Antibiotic transport in mycobacteria. Drug transport in antimicrobial and anticancer chemotherapy, N. H. Georgopapadakou. Marcel Dekker, Inc., New York 1995
   Google Scholar
• Bedard J., Bryan L. E. Interaction of the quinolone antimicrobial agents ciprofloxacin and enoxacin with liposomes. Antimicrob. Agents Chemother. 1989; 33: 1379–1382
   PubMed Web of Science ®Google Scholar
• Nikaido H., Thanassi D. G. Penetration of lipophilic with multiple protonation sites into bacterial cells: tetracyclines and quinolones as examples. Antimicrob. Agents Chemother. 1993; 37: 1393–1399
   PubMed Web of Science ®Google Scholar
• Georgopapadakou N. H. Quinolone uptake and efflux. Drug transport in antimicrobial and anticancer chemotherapy, N. H. Georgopapadakou. Marcel Dekker, Inc., New York 1995; 644
   Google Scholar
• Bedard J., Wong S., Bryan L. E. Accumulation of enoxacin italicopenEscherichia coli.italicclouse and italicopenBacillus subtilis.italicclouse Antimicrob. Agents Chemother. 1987; 31: 1348–1354
   PubMedGoogle Scholar
• Blaser J., Dudley M. N., Gilbert D., Zinner S. H. Influence of medium and method on the in vitro susceptibility of italicopenPseudomonas aeruginosaitalicclouse and other bacteria to ciprofloxacin and enoxacin. Antimicrob. Agents Chemother. 1986; 29: 927–929
   PubMed Web of Science ®Google Scholar
• Bryan L. E., Bedard J., Wong S., Chamberland S. Quinolone antibacterial agents: mechanism of action and resistance development. Clin. Invest. Med. 1989; 12: 14–19
   PubMed Web of Science ®Google Scholar
• Cohen S. P., Hooper D. C., Wolfron J. S., Souza K. S., McMurray L. M., Levy S. B. Endogeneous active efflux of norfloxacin in susceptible italicopenEscherichia coli.italicclouse Antimicrob. Agents Chemother. 1988; 32: 1187–1191
   PubMedGoogle Scholar
• Trias J., Jarlier V., Benz R. Porins in the cell wall of mycobacteria. Science 1992; 258: 1479–1481
   PubMed Web of Science ®Google Scholar
• Nikaido H., Kim S. H., Rosenberg E. Y. Physical organization of lipids in the cell wall italicopenof Mycobacterium chelonae.italicclouse. Mol. Microbiol. 1993; 8: 1025–1030
   PubMedGoogle Scholar
• Ambudkar S. V., Pastan I., Gottesman M. M. Cellular and biochemical aspects of multidrug resistance. Drug transport in antimicrobial and anticancer chemotherapy, N. H. Georgopapadakou. Marcel Dekker, Inc., New York 1995; 644
   Google Scholar
• Majumdar S., Flasher D., Friend D. S., Nassos P., Yajko D., Hadley W. K., Düzgünes N. Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against italicopenMycobacterium avium-M-intracellulareitalicclouse complex infections in human peripheral blood monocyte/macrophages. Antimicrob. Agents Chemother. 1992; 36: 2808–2815
   PubMed Web of Science ®Google Scholar
• Furet Y. X., Deshusses J., Pechere J. C. Transport of Pefloxacin across the bacterial cytoplasmic membrane in quinolonesusceptible italicopenStaphylococcus aureus.italicclouse Antimicrob. Agents Chemother. 1992; 36: 2506–2511
   PubMed Web of Science ®Google Scholar
• Hope M. J., Bally M. B., Welb G., CuUis P. R. Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution trapped volume and ability to maintain a membrane potential. Biochim. Biophys. Acta 1985; 812: 55–65
   PubMed Web of Science ®Google Scholar
• Van der Meeren P., Van Laethem M, Vanderdeelen J., Baert L. Particle sizing of liposomal dispersions: A critical evaluation of some quasi-elastic ligth-scattering data-analysis software programs. J. Liposome Res. 1992; 2: 23–42
   Google Scholar
• Nakhla A. N., Banoub H. J., Hernàndez-Borrell J., Keough K. M.W. Incorporation of bacterial lipopolysaccharide and polysacharide of italicopenAeromonas salmonicidaitalicclouse into liposomes is influenced by surface charge vesicle diameter and lipid to additive ratio. J. Liposome Res. 1996; 6: 141–154
   Google Scholar
• Keough K. M. W., Davis P. J. Thermal Analysis of membranes. Membrane fluidity, M. Kates, L. A. Manson. Plenum Publishing Corporation. 1984; 55–97
   Google Scholar
• Keough K. M. W., Davis P. J. Gel to liquid-crystalline phase transitions in water dispersions of saturated mixed-acid phosphatidylcholines. Biochemistry 1979; 18: 1453–1459
   PubMedGoogle Scholar
• Nag K., Boland C, Rich N. H., Keough K. M.W. Design and construction of an epifluorescence microscopic surface balance for the study of lipid monolayer phase transitions. Rev. Sci. Instrum. 1990; 61: 3425–3430
   Google Scholar
• Nag K., Boland C, Rich N., Keough K. M.W. Epifluorescence microscopic observation of monolayers of dipalmitoylphosphatidylcholine: dependence of domain size on compression rates. Biochim. Biophys. Acta 1991; 1068: 157–160
   PubMedGoogle Scholar
• Ross D. L., Elkinton S. K., Riley CM. Physicochemical properties of the quinolone antimicrobials. JXAcid ionization constants and their relationship to structure. Int. J. Pharm. 1992; 83: 267–272
   Google Scholar
• Ross D. L., Elkinton S. K., Riley CM. Physicochemical properties of the quinolone antimicrobials. III. 1-octanol/water partition coefficients and their relationships to structure. Int. J. Pharm. 1992; 88: 379–389
   Google Scholar
• Takácks-Novák K., Józan M., Hermecz I., Szász G. Lipophilicity of antibacterial quinolones. Int. J. Pharm. 1992; 79: 89–86
   Google Scholar
• Wong M., Anthony F. H., Tillack T. W., Thompson T. E. Fusion of dipalmitoylphosphatidylcholine vesicles at 4oC. Biochemistry 1982; 21: 4126–4132
   PubMed Web of Science ®Google Scholar
• Wong M., Thompson T. E. Agregation of dipalmitoylphosphatidyl-choline vesicles. Biochemistry 1982; 21: 4133–4138
   PubMed Web of Science ®Google Scholar
• Powers L., Pershun P. S. Monodomain samples of dipalmitoyl-phosphatidylcholine with varying concentrations of water and other ingredients. Biophys. J. 1977; 20: 137–152
   PubMed Web of Science ®Google Scholar
• Pérez-Gil J., Nag K., Taneva S., Keough K. M.W. Pulmonary surfactant protein SP-C alters the packing of dipalmitoylphosphatidylcholine in monolayers. Biophys. J. 1992; 63: 197–204
   PubMedGoogle Scholar
• Weiss R. M., McConnell H. M. Cholesterol stablizes the crystal-liquid interface in phospholipid monolayers. J. Phys. Chem. 1985; 89: 4453–4459
   Google Scholar